SMS Pharmaceuticals rose 4.81% to Rs 762.75 at 14:18 IST on BSE after the company said its board approved 10-for-1 stock split.
The announcement was made during trading hours today, 9 October 2015.
Meanwhile, the BSE Sensex was up 167.63 points, or 0.62%, to 27,013.44.
On BSE, so far 11,000 shares were traded in the counter, compared with an average volume of 6,908 shares in the past one quarter.
The stock hit a high of Rs 791 and a low of Rs 735 so far during the day. The stock hit a record high of Rs 820 on 6 August 2015. The stock hit a 52-week low of Rs 351.10 on 1 December 2014.
The stock had outperformed the market over the past one month till 8 October 2015, rising 32.74% compared with 6.04% rise in the Sensex. The scrip had also outperformed the market in past one quarter, rising 19.25% as against Sensex's 3.04% decline.
The small-cap company has an equity capital of Rs 8.47 crore. Face value per share is Rs 10.
Net profit of SMS Pharmaceuticals declined 11.98% to Rs 7.20 crore on 11.03% decline in net sales to Rs 113.20 crore in Q1 June 2015 over Q1 June 2014.
SMS Pharmaceuticals is a global player in active pharmaceutical ingredient (API) manufacturing.
Powered by Capital Market - Live News
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
